Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Vomiting 37Nausea 25Neoplasms 12Breast Neoplasms 6Lymphoma 3Stomach Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Rectal Neoplasms 2Multiple Myeloma 2Lymphoma, Non-Hodgkin 2Lung Neoplasms 2Leukemia 2Hematologic Neoplasms 2Colorectal Neoplasms 2Colonic Neoplasms 2Breast Neoplasms, Male 2Weight Loss 1Solid Tumors 1Sarcoma 1Radiation Injuries 1Pancreatic Neoplasms 1Pain 1Neoplasms, Germ Cell and Embryonal 1Nausea With Vomiting Chemotherapy-Induced 1Melanoma 1Liver Neoplasms 1Leukemia, Myeloid, Acute 1Inflammatory Breast Neoplasms 1Hematologic Diseases 1Glioma 1

Interventions

Palonosetron 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Nausea With Vomiting Chemotherapy-Induced × Palonosetron × Clear all
NCT04592198 2025-03-24

Buccal Film Versus IV Injection Palonosetron for Moderately Emetogenic Chemotherapy Induced Nausea and Vomiting

Xiamen LP Pharmaceutical Co., Ltd

Phase 2 Completed
22 enrolled 8 charts

Nausea With Vomiting Chemotherapy-Induced

Data powered by HemOnc (CC BY 4.0) Colophon âš¡